NICOTINELL TTS 30 TRANSDERMAL THERAPEUTIC SYSTEM 21 mg24 hrs

Country: Singapore

Language: English

Source: HSA (Health Sciences Authority)

Active ingredient:

NICOTINE

Available from:

GSK CONSUMER HEALTHCARE SINGAPORE PTE. LTD.

ATC code:

N07BA01

Dosage:

52.5 mg/30 sq cm

Pharmaceutical form:

PATCH

Composition:

NICOTINE 52.5 mg/30 sq cm

Administration route:

TRANSDERMAL

Prescription type:

Pharmacy Only

Manufactured by:

LTS LOHMANN THERAPIE-SYSTEME AG

Authorization status:

ACTIVE

Authorization date:

1991-11-12

Patient Information leaflet

Nicotinell TTS
Transdermal therapeutic system (TTS)
Aid to smoking cessation (on a scientific basis)
Composition
Active substance: nicotine, Transdermal therapeutic
system (TTS) with a contact surface of 10cm
2
, 20cm
2
or 30cm
2
.
1 Nicotinell TTS 10 contains 17.5mg nicotine. The aver-
age rate of active substance released onto the skin is
7 mg/24 hours.
1 Nicotinell TTS 20 contains 35mg nicotine. The aver-
age rate of active substance released onto the skin is
14 mg/24 hours.
1 Nicotinell TTS 30 contains 52.5mg nicotine. The aver-
age rate of active substance released onto the skin is
21 mg/24 hours
Indications/Methods of use
To aid smoking cessation; to reduce addictive behavior
and the various withdrawal symptoms in nicotine-
dependent smokers. Treatment should not exceed
3 months. Data currently available show that application
of Nicotinell TTS compared with placebo is effective in
the short term.
The long-term success of treatment after smoking cessa-
tion does not depend on Nicotinell TTS, but is essentially
determined by the patient’s willpower and any further
psychological support he or she may be receiving.
Dosage/Directions for use
The patient should be told to stop smoking completely
as soon as treatment with Nicotinell TTS is started.
Nicotinell TTS is intended for use in adults over the age
of 18 years. If you are under 18 years old, ask a health-
care professional before use. One Nicotinell TTS should
be applied daily and left on the skin for 24 hours. Since
the amount of nicotine released from
Nicotinell TTS per
cm
2
is constant, the dose administered is determined
solely by the contact area of the system. To avoid local
irritation of the skin, a new site of application should
be chosen each day. Nicotinell TTS is available in three
dosage strengths:
Nicotinell TTS 30, Nicotinell TTS 20
and Nicotinell TTS 10.
The dosage cannot be adjusted by cutting the TTS
transdermic system.
Nicotinell TTS 30 is generally intended for smokers
with a consumption of more than 20 cigarettes a day.
Nicotinell TTS

Summary of Product characteristics

Nicotinell TTS
Transdermal therapeutic system (TTS)
Aid to smoking cessation (on a scientific basis)
Composition
Active substance: nicotine, Transdermal therapeutic
system (TTS) with a contact surface of 10cm
2
, 20cm
2
or 30cm
2
.
1 Nicotinell TTS 10 contains 17.5mg nicotine. The aver-
age rate of active substance released onto the skin is
7 mg/24 hours.
1 Nicotinell TTS 20 contains 35mg nicotine. The aver-
age rate of active substance released onto the skin is
14 mg/24 hours.
1 Nicotinell TTS 30 contains 52.5mg nicotine. The aver-
age rate of active substance released onto the skin is
21 mg/24 hours
Indications/Methods of use
To aid smoking cessation; to reduce addictive behavior
and the various withdrawal symptoms in nicotine-
dependent smokers. Treatment should not exceed
3 months. Data currently available show that application
of Nicotinell TTS compared with placebo is effective in
the short term.
The long-term success of treatment after smoking cessa-
tion does not depend on Nicotinell TTS, but is essentially
determined by the patient’s willpower and any further
psychological support he or she may be receiving.
Dosage/Directions for use
The patient should be told to stop smoking completely
as soon as treatment with Nicotinell TTS is started.
Nicotinell TTS is intended for use in adults over the age
of 18 years. If you are under 18 years old, ask a health-
care professional before use. One Nicotinell TTS should
be applied daily and left on the skin for 24 hours. Since
the amount of nicotine released from Nicotinell TTS per
cm
2
is constant, the dose administered is determined
solely by the contact area of the system. To avoid local
irritation of the skin, a new site of application should
be chosen each day. Nicotinell TTS is available in three
dosage strengths: Nicotinell TTS 30, Nicotinell TTS 20
and Nicotinell TTS 10.
The dosage cannot be adjusted by cutting the TTS
transdermic system.
Nicotinell TTS 30 is generally intended for smokers
with a consumption of more than 20 cigarettes a day.
Nicotinell TTS